Combining oncolytic virotherapy and tumour vaccination

被引：30

作者：

Bridle, Byram W. ^{[1
]}

Hanson, Stephen ^{[1
]}

Lichty, Brian D. ^{[1
]}

机构：

[1] McMaster Univ, Dept Pathol & Mol Med, Ctr Gene Therapeut, Hamilton, ON L8N 3Z5, Canada

来源：

CYTOKINE & GROWTH FACTOR REVIEWS | 2010年 / 21卷 / 2-3期

关键词：

Oncolytic virus; Tumour vaccine; Prime: boost; Anti-tumour immunity; POTENT ANTITUMOR IMMUNITY; HERPES-SIMPLEX-VIRUS; REGULATORY T-CELLS; PROSTATIC ACID-PHOSPHATASE; VESICULAR STOMATITIS-VIRUS; RECOMBINANT VACCINIA VIRUS; DENDRITIC CELLS; CANCER-PATIENTS; DIVERSIFIED PRIME; COLORECTAL-CANCER;

D O I：

10.1016/j.cytogfr.2010.02.009

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The interactions between the immune system, a malignant tumour and an oncolytic virus are complex and poorly understood. For oncolytic viruses to become successful therapeutics we need to better understand these interactions and identify strategies to take advantage of defects in the innate immune response within tumours and avoid cellular anti-viral responses while capitalizing on anti-tumoural immunity. In this review we will discuss the evidence for the induction of tumour-specific immune responses by oncolytic viruses as well as by cancer vaccines. We will then describe some of the barriers to successful cancer immunotherapy, and finally we will outline a strategy for enhancing anti-tumoural immunity while reducing anti-viral immunity by combining tumour vaccination with oncolytic viral therapy. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：143 / 148

页数：6

共 79 条

[11] Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses [J].

Di Paolo, NC ;

Tuve, S ;

Ni, SH ;

Hellström, KE ;

Hellström, I ;

Lieber, A .

CANCER RESEARCH, 2006, 66 (02) :960-969

[12] Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus [J].

Diaz, Rosa Maria ;

Galivo, Feorillo ;

Kottke, Timothy ;

Wongthida, Phonphimon ;

Qiao, Jian ;

Thompson, Jill ;

Valdes, Mikael ;

Barber, Glen ;

Vile, Richard G. .

CANCER RESEARCH, 2007, 67 (06) :2840-2848

[13] Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer [J].

Disis, Mary L. ;

Wallace, Danelle R. ;

Gooley, Theodore A. ;

Dang, Yushe ;

Slota, Meredith ;

Lu, Hailing ;

Coveler, Andrew L. ;

Childs, Jennifer S. ;

Higgins, Doreen M. ;

Fintak, Patricia A. ;

dela Rosa, Corazon ;

Tietje, Kathleen ;

Link, John ;

Waisman, James ;

Salazar, Lupe G. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) :4685-4692

[14] Heteroclitic immunization induces tumor immunity [J].

Dyall, R ;

Bowne, WB ;

Weber, LW ;

LeMaoult, J ;

Szabo, P ;

Moroi, Y ;

Piskun, G ;

Lewis, JJ ;

Houghton, AN ;

Nikolic-Zugic, J .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) :1553-1561

[15] Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox virus (ALVAC) cytokine gene delivery induces destruction of established prostate tumors [J].

Elzey, BD ;

Siemens, DR ;

Ratliff, TL ;

Lubaroff, DM .

INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (06) :842-849

[16] In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer [J].

Endo, T ;

Toda, M ;

Watanabe, M ;

Iizuka, Y ;

Kubota, T ;

Kitajima, M ;

Kawakami, Y .

CANCER GENE THERAPY, 2002, 9 (02) :142-148

[17] A changing world for DCvax: a PSMA loaded autologous dendritic cell vaccine for prostate cancer [J].

Fishman, Mayer .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (12) :1565-1575

[18] Selecting and maintaining a diverse T-cell repertoire [J].

Goldrath, AW ;

Bevan, MJ .

NATURE, 1999, 402 (6759) :255-262

[19] Vaccines for the Treatment of Non-Small Cell Lung Cancer: A Renewed Anticancer Strategy [J].

Gridelli, Cesare ;

Rossi, Antonio ;

Maione, Paolo ;

Ferrara, Marianna Luciana ;

Castaldo, Vincenzo ;

Sacco, Paola Claudia .

ONCOLOGIST, 2009, 14 (09) :909-920

[20] New insights into the molecular mechanism of interieukin-10-mediated immunosuppression [J].

Grütz, G .

JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 77 (01) :3-15

← 1 2 3 4 5 6 7 8 →